Darolutamide (Nubeqa®) 300 mg tablets Clinical Trials

2 recruitingDrug

Phase 11

Status

RecruitingNot yet recruitingEnrolling by invitationActive, not recruiting

Sex

MaleFemale

Your Age

Shows trials you qualify for by age

Phase

Phase 1Phase 2Phase 3Phase 4Early Phase 1Not Applicable

Study Type

InterventionalObservational

Country

United StatesCanadaUnited KingdomAustraliaGermanyFranceSpainItaly

Related Interventions

Enzalutamide47
Apalutamide (Erleada™) 60 mg or 240 mg tablets2
Taxotere (docetaxel)2

Showing 1–2 of 2 trials

Recruiting

Phase 1

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

Metastatic Prostate Cancer

ORIC Pharmaceuticals250 enrolled27 locationsNCT05413421

Recruiting

PSA Biochemical Response as Prognostic Factor in Metastatic Castration-Sensitive Prostate Cancer

Prostate CancerMetastatic CancerCastrate Sensitive Prostate Cancer

Fondazione Policlinico Universitario Agostino Gemelli IRCCS152 enrolled1 locationNCT06652607

ClinicalTrialsFinder

Helping patients and researchers find recruiting clinical trials. Updated regularly from ClinicalTrials.gov and ANZCTR.

Browse

Browse Conditions
Browse Drugs
Browse Locations
Browse Institutions
Search Trials
Get Trial Alerts

Resources

Clinical Trial Guides
FAQ
About Us
Contact
Partnerships
ClinicalTrials.gov
ANZCTR

Data Source

Trial data sourced from ClinicalTrials.gov and ANZCTR (Australian New Zealand Clinical Trials Registry)

Updated regularly to reflect the latest trial information

Medical Disclaimer: This site is for informational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider before making decisions about participating in a clinical trial. Trial information may change; verify details directly with the trial sponsor or at the relevant registry (ClinicalTrials.gov or ANZCTR).

|

Privacy Policy Terms of Service

Data provided by ClinicalTrials.gov & ANZCTR